Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: invest04 who wrote (5120)	5/27/1999 12:34:00 AM
From: Bill Wexler	Read Replies (3) \| Respond to of 5736

<<Wexler is screaming "fraud, fraud, fraud"...>> I'm not screaming. I'm only stating the obvious. CCSI has a history of fraudulent stock promotion. They are associated with criminals who were indicted for securities fraud. Bruce Meyers and Peter Janssen are major stockholders as well as major scumbags. CCSI financial condition is dire, and it's only product is stock certificates. These facts are not disputable. The bottom line here is that any discussion of Bilirubinometers is meaningless since the primary goal of CCSI managment is not to market their worthless device, it is to sell more stock to more victims.

To: invest04 who wrote (5120)	5/27/1999 12:25:00 PM
From: Peter V	Read Replies (2) \| Respond to of 5736

<<so what are you worried about?>> I'm not worried at all. If you won't share your thoughts, why are you posting? I think Wexler can dig himself out of any hole without your help, so that excuse doesn't hold much water. I'm sorry if you don't think my posts constitute a rational, reasonable or intelligent exchange, but I've tried. Don't drag Yahoo into this, I'm not posting there. If you don't want to add anything to what I have said, why post? All you have done so far is say that I am wrong, without any substantive backup, and then blame others for your failure to post any analysis of this stock.